(E)-4,5,6,7-tetrachloro-2-(2-(2-(thiazol-2-yl)vinyl)phenyl)isoindoline-1,3-dione

ID: ALA4204457

Chembl Id: CHEMBL4204457

PubChem CID: 145975104

Max Phase: Preclinical

Molecular Formula: C19H8Cl4N2O2S

Molecular Weight: 470.16

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1c2c(Cl)c(Cl)c(Cl)c(Cl)c2C(=O)N1c1ccccc1/C=C/c1nccs1

Standard InChI:  InChI=1S/C19H8Cl4N2O2S/c20-14-12-13(15(21)17(23)16(14)22)19(27)25(18(12)26)10-4-2-1-3-9(10)5-6-11-24-7-8-28-11/h1-8H/b6-5+

Standard InChI Key:  PRWXVIIRASLOJH-AATRIKPKSA-N

Alternative Forms

  1. Parent:

    ALA4204457

    ---

Associated Targets(Human)

NR1H3 Tchem LXR-alpha (2891 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR1H2 Tchem LXR-beta (3841 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Nr1h3 Oxysterols receptor LXR-alpha (8 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nr1h2 Oxysterols receptor LXR-beta (116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 470.16Molecular Weight (Monoisotopic): 467.9061AlogP: 6.73#Rotatable Bonds: 3
Polar Surface Area: 50.27Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 2.74CX LogP: 6.22CX LogD: 6.22
Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.24Np Likeness Score: -0.95

References

1. Nomura S, Endo-Umeda K, Fujii S, Makishima M, Hashimoto Y, Ishikawa M..  (2018)  Structural development of tetrachlorophthalimides as liver X receptor β (LXRβ)-selective agonists with improved aqueous solubility.,  28  (4): [PMID:29398545] [10.1016/j.bmcl.2017.12.024]

Source